These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38216371)

  • 1. Corrigendum to "N-arachidonoylphenolamine alleviates ischaemia/reperfusion-induced cardiomyocyte necroptosis by restoring proteasomal activity" [Eur. J. Pharmacol. (2024) 963 176235].
    Bai JQ; Li PB; Li CM; Li HH
    Eur J Pharmacol; 2024 Feb; 965():176316. PubMed ID: 38216371
    [No Abstract]   [Full Text] [Related]  

  • 2. N-arachidonoylphenolamine alleviates ischaemia/reperfusion-induced cardiomyocyte necroptosis by restoring proteasomal activity.
    Bai JQ; Li PB; Li CM; Li HH
    Eur J Pharmacol; 2024 Jan; 963():176235. PubMed ID: 38096967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum to 'Echinocystic acid, a natural plant extract, alleviates cerebral ischemia/reperfusion injury via inhibiting the JNK signaling pathway' [Eur. J. Pharmacol., 861 (2019 oct 15), 172610].
    Yu H; Li W; Cao X; Wang X; Zhao Y; Song L; Chen J; Wang S; Chen B; Xu Y
    Eur J Pharmacol; 2021 Feb; 892():173790. PubMed ID: 33308992
    [No Abstract]   [Full Text] [Related]  

  • 4. Corrigendum to "Guggulsterone inhibits migration and invasion through proteasomal and lysosomal degradation in human glioblastoma cells" [Eur. J. Pharmacol. 938 (2023) 175411].
    Yang JF; Chang HH; Chen TM; Tsai WC; Huang WY; Lo CH; Lin CS; Shen PC; Chen Y
    Eur J Pharmacol; 2023 Dec; 960():176183. PubMed ID: 37953156
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to "Pretreatment with obestatin reduces the severity of ischemia/reperfusion-induced acute pancreatitis in rats" [Eur. J. Pharmacol. 760 (2015) 113-121].
    Bukowczan J; Warzecha Z; Ceranowicz P; Kuśnierz-Cabala B; Tomaszewska R; Dembinski A
    Eur J Pharmacol; 2019 Jan; 842():384-385. PubMed ID: 30554633
    [No Abstract]   [Full Text] [Related]  

  • 6. Corrigendum to "Protective effects of sitagliptin on myocardial injury and cardiac function in an ischemia/reperfusion rat model" [Eur J Pharmacol. 718 (1-3) (2013) 105-13].
    Chang G; Zhang P; Ye L; Lu K; Wang Y; Duan Q; Zheng A; Qin S; Zhang D
    Eur J Pharmacol; 2020 Feb; 869():172876. PubMed ID: 31877280
    [No Abstract]   [Full Text] [Related]  

  • 7. MiR-24 alleviates cardiomyocyte apoptosis after myocardial infarction via targeting BIM.
    Pan LJ; Wang X; Ling Y; Gong H
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7549. PubMed ID: 32744654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of DJ-1 expression protects cardiomyocyte apoptosis induced by ischemia reperfusion.
    Xin LH; Liu WJ; Song T; Zhang L
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):11988. PubMed ID: 33336715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corrigendum to "Flaccidoside II ameliorates collagen-induced arthritis in mice" [Eur. J. Pharmacol. 880 (2020) 173155].
    Zhang GB; Jia ZJ; Zhang MH; Li YJ; Tian LY; Cheng J
    Eur J Pharmacol; 2021 Apr; 897():173963. PubMed ID: 33674037
    [No Abstract]   [Full Text] [Related]  

  • 10. Knockdown of lncRNA AK139328 alleviates myocardial ischaemia/reperfusion injury in diabetic mice via modulating miR-204-3p and inhibiting autophagy.
    Yu SY; Dong B; Fang ZF; Hu XQ; Tang L; Zhou SH
    J Cell Mol Med; 2018 Oct; 22(10):4886-4898. PubMed ID: 30047214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corrigendum to "Vitexin protects against ethanol-induced liver injury through Sirt1/p53 signaling pathway" [Eur. J. Pharmacol. 873 (2020) 173007].
    Yuan H; Duan S; Guan T; Yuan X; Lin J; Hou S; Lai X; Huang S; Du X; Chen S
    Eur J Pharmacol; 2020 Aug; 880():173160. PubMed ID: 32460965
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to 'Dezocine attenuates the remifentanil-induced postoperative hyperalgesia by inhibition of phosphorylation of CaMKⅡα' [Eur J Pharmacol. 2020 Feb 15; 869: 172882].
    Zhou J; Qi F; Hu Z; Zhang L; Li Z; Wang ZJ; Tang H; Chen Z
    Eur J Pharmacol; 2021 Oct; 908():174359. PubMed ID: 34298417
    [No Abstract]   [Full Text] [Related]  

  • 13. Corrigendum to "Protective effects of cortex fraxini coumarines against oxonate-induced hyperuricemia and renal dysfunction in mice" [Eur. J. Pharmacol. 666 (2011) 196-204].
    Li JM; Zhang X; Wang X; Xie YC; Kong LD
    Eur J Pharmacol; 2022 Feb; 916():174740. PubMed ID: 34996605
    [No Abstract]   [Full Text] [Related]  

  • 14. Corrigendum to "Exenatide ameliorates hydrogen peroxide-induced pancreatic β-cell apoptosis through regulation of METTL3-mediated m
    Zhou S; Sun Y; Xing Y; Wang Z; Wan S; Yao X; Hua Q; Meng X; Cheng J; Zhong M; Lv K; Kong X
    Eur J Pharmacol; 2023 May; 946():175652. PubMed ID: 36924576
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to "Essential role of Ca
    Tsubota M; Matsui K; Nakano M; Kajitani R; Ishii Y; Tomochika K; Nishikawa Y; Fukushi S; Yamagata A; Sekiguchi F; Okada T; Toyooka N; Kawabata A
    Eur J Pharmacol; 2021 Feb; 892():173795. PubMed ID: 33358247
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to "Magnesium isoglycyrrhizinate blocks fructose-induced hepatic NF-κB/NLRP3 inflammasome activation and lipid metabolism disorder" [Eur. J. Pharmacol. 15 (2017) 809: 141-150].
    Zhao XJ; Yang YZ; Zheng YJ; Wang SC; Gu HM; Pan Y; Wang SJ; Xu HJ; Kong LD
    Eur J Pharmacol; 2021 Oct; 909():174440. PubMed ID: 34450555
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to "siRNA: Mechanism of action, challenges, and therapeutic approaches" [Eur. J. Pharmacol. 905 (2021) 174178].
    Alshaer W; Zureigat H; Al Karaki A; Al-Kadash A; Gharaibeh L; Hatmal MM; Aljabali AAA; Awidi A
    Eur J Pharmacol; 2022 Feb; 916():174741. PubMed ID: 34998574
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to "α-Conidendrin inhibits the expression of intercellular adhesion molecule-1 induced by tumor necrosis factor-α in human adenocarcinoma A549 cells" [Eur. J. Pharmacol. 890 (2021) 173651].
    Vo NT; Sasaki S; Miyake Y; Nguyen NT; Dang PH; Thi Nguyen MT; Kataoka T
    Eur J Pharmacol; 2021 Oct; 909():174453. PubMed ID: 34462123
    [No Abstract]   [Full Text] [Related]  

  • 19. Corrigendum to 'Saxagliptin ameliorated the depressive-like behavior induced by chronic unpredictable mild stress in rats: Impact on incretins and AKT/PI3K pathway' [Eur. J. Pharmacol. 912 (2021) 174602].
    Nazeem M; Wahdan SA; El-Naga RN; Gad AM
    Eur J Pharmacol; 2023 Jul; 950():175779. PubMed ID: 37179133
    [No Abstract]   [Full Text] [Related]  

  • 20. Corrigendum to 'Reduced nitric oxide-mediated relaxation and endothelial nitric oxide synthase expression in the tail arteries of streptozotocin-induced diabetic rats' [Eur. J. Pharmacol. 773 (2016) 78-84].
    Mokhtar SS; Vanhoutte PM; Leung SWS; Suppian R; Yusof MI; Rasool AHG
    Eur J Pharmacol; 2017 Oct; 812():264. PubMed ID: 28915977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.